# K122757

<table><tr><td>510(k) Owner:</td><td>Contact:</td><td>Alfa Wassermann Diagnostic Technologies, LLC 4 Henderson Drive West Caldwell, NJ 07006 Hyman Katz, Ph.D. Phone: 973-852-0158</td></tr><tr><td>Date Summary</td><td colspan="2">Fax: 973-852-0237 September 6, 2012</td></tr><tr><td>Prepared: Device:</td><td colspan="2">Trade Name: ACE Cholesterol Reagent Classification: Class 1, meets limitations of exemption per 21 CFR § 862.9(c)(4)</td></tr><tr><td rowspan="8"></td><td colspan="2">and (c)(9)</td></tr><tr><td colspan="2">Common/Classification Name: Enzymatic Esterase-Oxidase, Cholesterol (21 CFR § 862.1175)</td></tr><tr><td colspan="2">Product Code CHH</td></tr><tr><td colspan="2">Trade Name: ACE HDL-C Reagent Classification: Class 1, meets limitations of exemption per 21 CFR § 862.9(c)(4)</td></tr><tr><td colspan="2">and (c)(9) Common/Classification Name: LDL &amp; VLDL Precipitation, Cholesterol Via</td></tr><tr><td colspan="2">Esterase-Oxidase, HDL (21 CFR § 862.1475)</td></tr><tr><td colspan="2">Product Code LBS ACE LDL-C Reagent</td></tr><tr><td colspan="2">Trade Name: Classification: Class 1, meets limitations of exemption per 21 CFR § 862.9(c)(4) and (c)(9)</td></tr><tr><td colspan="2">Common/Classification Name: System, Test, Low Density, Lipoprotein</td></tr><tr><td colspan="2">(21 CFR § 862.1475) Product Code MRR Trade Name:</td></tr><tr><td colspan="2">ACE Triglycerides Reagent Classification: Class 1, meets limitations of exemption per 21 CFR  862.9(c)(4)</td></tr><tr><td colspan="2">and (c)(9)</td></tr><tr><td colspan="2">Common/Classification Name: Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides</td></tr><tr><td colspan="2">(21 CFR § 862.1705) Product Code CDT Predicates:</td></tr><tr><td></td><td>ACE Cholesterol Reagent (k113262) ACE HDL-C Reagent (k113262) ACE LDL-C Reagent (k113262)</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Similarities</td><td colspan="1" rowspan="1">Candidate Device</td><td colspan="1" rowspan="1">Predicate Device</td></tr><tr><td colspan="1" rowspan="1">510(k)#</td><td colspan="1" rowspan="1">k122757</td><td colspan="1" rowspan="1">K113262</td></tr><tr><td colspan="1" rowspan="1">Company</td><td colspan="1" rowspan="1">Alfa WassermannDiagnostic Technologies,LLC</td><td colspan="1" rowspan="1">Alfa Wassermann DiagnosticTechnologies, LLC</td></tr><tr><td colspan="1" rowspan="1">Name</td><td colspan="1" rowspan="1">ACE Axcel ClinicalChemistry System, ACECholesterol Reagent</td><td colspan="1" rowspan="1">ACE Axcel Clinical ChemistrySystem, ACE Cholesterol Reagent</td></tr><tr><td colspan="1" rowspan="1">Intended Use/Indicationsfor Use</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">The ACE Cholesterol Reagent isintended for the quantitativedetermination of cholesterolconcentration using the ACEAxcel Clinical Chemistry System.Cholesterol measurements areused in the diagnosis andtreatment of disorders involvingexcess cholesterol in the bloodand lipid and lipoproteinmetabolism disorders. This test isintended for use in clinicallaboratories or physician officelaboratories. For in vitrodiagnostic use only.</td></tr><tr><td colspan="1" rowspan="1">InstrumentPlatform</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">ACE Axcel Clinical ChemistrySystem</td></tr><tr><td colspan="1" rowspan="1">BasicPrinciple</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Enzymatic method for cholesterol</td></tr><tr><td colspan="1" rowspan="1">ReagentCompositionReactiveIngredients</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">4-Aminoantipyrenep-Hydroxybenzoic acidCholesterol oxidase (Nocardia)Cholesterol esterase (porcinepancreas and Pseudomonas)Peroxidase (Horseradish)</td></tr><tr><td colspan="1" rowspan="1">Differences</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">SampleType</td><td colspan="1" rowspan="1">Serum and lithium heparinplasma</td><td colspan="1" rowspan="1">Serum</td></tr><tr><td colspan="3" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Company</td><td colspan="1" rowspan="1">Alfa WassermannDiagnostic Technologies,LLC</td><td colspan="1" rowspan="1">Alfa WassermannDiagnosticTechnologies, LLC</td></tr><tr><td colspan="1" rowspan="1">Name</td><td colspan="1" rowspan="1">ACE Axcel ClinicalChemistry System, ACEHDL-C Reagent</td><td colspan="1" rowspan="1">ACE Axcel Clinical ChemistrySystem, ACE HDL-C Reagent</td></tr><tr><td colspan="1" rowspan="1">Intended Use/Indicationsfor Use</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">The ACE HDL-C Reagent isintended for the quantitativedetermination of high densitylipoprotein cholesterol (HDL-C)concentration using the ACEAxcel Clinical ChemistrySystem. Lipoproteinmeasurements are used in thediagnosis and treatment of lipiddisorders (such as diabetesmellitus), atherosclerosis andvarious liver and renal diseases.This test is intended for use inclinical laboratories or physicianoffice laboratories. For in vitrodiagnostic use only.</td></tr><tr><td colspan="1" rowspan="1">InstrumentPlatform</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">ACE Axcel Clinical ChemistrySystem</td></tr><tr><td colspan="1" rowspan="1">BasicPrinciple</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Detergent solubilization ofHDL to selectively measureHDL cholesterol using anenzymatic method.</td></tr><tr><td colspan="1" rowspan="1">ReagentCompositionReactiveIngredients</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Cholesterol oxidase (E. coli)Peroxidase (Horseradish)N, N-bis(4-sulphobutyl)-m-toluidine-disodium saltAcceleratorAscorbic oxidase (Curcurbitasp.)4-AminoantipyreneCholesterol esterase(Pseudomonas)</td></tr><tr><td colspan="1" rowspan="1">Differences</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Sample Type</td><td colspan="1" rowspan="1">Serum and lithium heparinplasma</td><td colspan="1" rowspan="1">Serum</td></tr><tr><td colspan="1" rowspan="1">Company</td><td colspan="1" rowspan="1">Alfa WassermannDiagnostic Technologies,LLC</td><td colspan="1" rowspan="1">Alfa Wassermann DiagnosticTechnologies, LLC</td></tr><tr><td colspan="1" rowspan="1">Name</td><td colspan="1" rowspan="1">ACE Axcel ClinicalChemistry System, ACELDL-C Reagent</td><td colspan="1" rowspan="1">ACE Axcel Clinical ChemistrySystem, ACE LDL-C Reagent</td></tr><tr><td colspan="1" rowspan="1">Intended Use/Indicationsfor Use</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">The ACE LDL-C Reagent isintended for the quantitativedetermination of low densitylipoprotein cholesterol (LDL-C)concentration using the ACEAxcel Clinical ChemistrySystem. Lipoproteinmeasurements are used in thediagnosis and treatment of lipiddisorders (such as diabetesmellitus), atherosclerosis andvarious liver and renal diseases.This test is intended for use inclinical laboratories or physicianoffice laboratories. For in vitrodiagnostic use only.</td></tr><tr><td colspan="1" rowspan="1">InstrumentPlatform</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">ACE Axcel Clinical ChemistrySystem</td></tr><tr><td colspan="1" rowspan="1">BasicPrinciple</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Detergent solubilization of LDLto selectively measure LDLcholesterol using an enzymaticmethod</td></tr><tr><td colspan="1" rowspan="1">ReagentCompositionReactiveIngredients</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Cholesterol esteraseCholesterol oxidasePeroxidase4-AminoantipyrineAscorbic acid oxidaseBufferN,N-bis (4-sulfobutyl)-m-toluidine, disodium salt</td></tr><tr><td colspan="1" rowspan="1">Differences</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Sample Type</td><td colspan="1" rowspan="1">Serum and lithium heparinplasima</td><td colspan="1" rowspan="1">Serum</td></tr></table>

<table><tr><td colspan="1" rowspan="10"></td><td colspan="1" rowspan="1">Similarities</td><td colspan="1" rowspan="1">Candidate Device</td><td colspan="1" rowspan="1">Predicate Device</td></tr><tr><td colspan="1" rowspan="1">510(k)#</td><td colspan="1" rowspan="1">k122757</td><td colspan="1" rowspan="1">K113262</td></tr><tr><td colspan="1" rowspan="1">Company</td><td colspan="1" rowspan="1">Alfa WassermannDiagnostic Technologies,LLC</td><td colspan="1" rowspan="1">Alfa Wassermann DiagnosticTechnologies, LLC</td></tr><tr><td colspan="1" rowspan="1">Name</td><td colspan="1" rowspan="1">ACE Axcel ClinicalChemistry System, ACETriglycerides Reagent</td><td colspan="1" rowspan="1">ACE Axcel Clinical ChemistrySystem, ACE TriglyceridesReagent</td></tr><tr><td colspan="1" rowspan="1">Intended Use/Indicationsfor Use</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">The ACE Triglycerides Reagentis intended for the quantitativedetermination of triglycerideconcentration using the ACEAxcel Clinical ChemistrySystem. Triglyceridemeasurements are used in thediagnosis and treatment ofpatients with diabetes mellitus,nephrosis, liver obstruction,other diseases involving lipidmetabolism or various endocrinedisorders. This test is intendedfor use in clinical laboratories orphysician office laboratories.For in vitro diagnostic use only.</td></tr><tr><td colspan="1" rowspan="1">InstrumentPlatform</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">ACE Axcel Clinical ChemistrySystem</td></tr><tr><td colspan="1" rowspan="1">BasicPrinciple</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Coupled enzymatic reaction</td></tr><tr><td colspan="1" rowspan="1">ReagentCompositionReactiveIngredients</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">4-Aminoantipyrineadenosine 5'-triphosphatep-ChlorophenolGlycerol phosphate oxidase(Microorganism)Lipase (Pseudomonas)Peroxidase (Horseradish)Glycerol kinase (Cellulomonas)</td></tr><tr><td colspan="1" rowspan="1">Differences</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Sample Type</td><td colspan="1" rowspan="1">Serum and lithium heparinplasma</td><td colspan="1" rowspan="1">Serum</td></tr><tr><td colspan="1" rowspan="1">DeviceDescriptions:</td><td colspan="3" rowspan="1">In the ACE Cholesterol Reagent assay, cholesterol esters in serum are completelyhydrolyzed by cholesterol esterase to free cholesterol and free fatty acids. Thecholesterol liberated by the esterase, plus any endogenous free cholesterol, areboth oxidized by cholesterol oxidase to yield hydrogen peroxide. The hydrogenperoxide then acts to oxidatively couple p-hydroxybenzoic acid and 4-amin-oantipyrine in a reaction catalyzed by peroxidase, producing a red colored</td></tr><tr><td>concentration in the sample. concentration in the sample. Intended Use: Indications for Use: cholesterol concentration in serum and lithium heparin plasma using the ACE Axcel Clinical Chemistry System. Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders. This test is intended for use in clinical</td><td>detergent also inhibits the reaction of the cholesterol enzymes with LDL, VLDL and chylomicron lipoproteins by adsorbing to their surfaces. The amount of chromogen formed, determined by measuring the increase in absorbance bichromatically at 592/692 nm, is directly proportional to the HDL cholesterol In the ACE LDL-C Reagent assay, detergent 1 solubilizes non-LDL lipoprotein particles (HDL, VLDL and chylomicrons) and releases cholesterol. The cholesterol is consumed by cholesterol esterase and cholesterol oxidase in a non- color forming reaction. In a second reaction, detergent 2 solublizes the remaining LDL particles and forms peroxide, via the enzymes cholesterol esterase and cholesterol oxidase. The peroxide, in the presence of peroxidase and two peroxidase substrates, 4-aminoantipyrine and DSBmT, results in a purple-red color. The amount of color formed, determined by measuring the increase in absorbance bichromatically at 544/692 nm, is directly proportional to the LDL cholesterol concentration in the sample. In the ACE Triglycerides Reagent assay, triglycerides in serum are hydrolyzed by lipase to form glycerol and free fatty acids. In the presence of adenosine triphosphate (ATP) and glycerol kinase, the glycerol is converted to glycerol-1- phosphate and the ATP to adenosine diphosphate. Glycerol-1-phosphate is oxidized by glycerol phosphate oxidase to yield hydrogen peroxide. The hydrogen peroxide then acts to oxidatively couple p-chlorophenol and 4- aminoantipyrine in a reaction catalyzed by peroxidase, producing a red colored quinoneimine complex which absorbs strongly at 505 nm. The amount of chromogen formed, determined by measuring the increase in absorbance bichromatically at 505 nm/692 nm, is directly proportional to the triglycerides The ACE Cholesterol Reagent is intended for the quantitative determination of</td></tr><tr><td>Axcel Clinical Chemistry System. Triglyceride measurements are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases involving lipid metabolism or various endocrine</td><td>The ACE HDL-C Reagent is intended for the quantitative determination of high density lipoprotein cholesterol (HDL-C) concentration in serum and lithium heparin plasma using the ACE Axcel Clinical Chemistry System. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only. The ACE LDL-C Reagent is intended for the quantitative determination of low density lipoprotein cholesterol (LDL-C) concentration in serum and lithium heparin plasma using the ACE Axcel Clinical Chemistry System. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only. The ACE Triglycerides Reagent is intended for the quantitative determination of triglyceride concentration in serum and lithium heparin plasma using the ACE</td></tr><tr><td>Technological Characteristics: esterase, cholesterol oxidase, peroxidase, 4-aminoantipyrine, ascorbic acid oxidase, detergent 2 and N,N-bis(4-sulphobutyl)-m-toluidine-disodium salt.</td><td>disorders. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only. The ACE Cholesterol Reagent is composed of a single reagent bottle. The reagent contains 4-aminoantipyrine, p-hydroxybenzoic acid, cholesterol oxidase, cholesterol esterase and peroxidase. The ACE HDL-C Reagent is composed of two reagent bottles (Buffer and Color Reagent). The reagents contain Good's buffer, cholesterol oxidase, peroxidase, N,N-bis(4-sulphobutyl)-m-toluidine-disodium salt, ascorbic oxidase, cholesterol esterase 4-aminoantipyrine and a detergent. The ACE LDL-C Reagent is composed of two reagent bottles (Buffer and Color Reagent). The reagents contain MES Buffer (pH 6.3), detergent 1, cholesterol</td></tr><tr><td>Performance Data:</td><td>glycerol phosphate oxidase, lipase, peroxidase and glycerol kinase. Performance data for the Alfa Wassermann ACE Reagents run on the Alfa Wassermann ACE Axcel Clinical Chemistry System included matrix comparison data and precision/reproducibility data. Precision/Reproducibility:</td></tr></table>

Precision was evaluated following the guideline EP10-A3. Two replicates each of 3 levels of samples at clinically relevant decision levels were tested twice a day on 5 separate days, yielding 20 replicates total. The results are presented in the tables below:

<table><tr><td rowspan=2 colspan=1>AnalyteCholesterolmg/dL</td><td rowspan=1 colspan=5>Precision (SD, %CV)</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Serum Low</td><td rowspan=1 colspan=1>150.9</td><td rowspan=1 colspan=1>2.3, 1.5%</td><td rowspan=1 colspan=1>0.0,0.0%</td><td rowspan=1 colspan=1>0.8, 0.6%</td><td rowspan=1 colspan=1>2.4, 1.6%</td></tr><tr><td rowspan=1 colspan=1>Serum Mid</td><td rowspan=1 colspan=1>252.5</td><td rowspan=1 colspan=1>2.5, 1.0%</td><td rowspan=1 colspan=1>2.5, 1.0%</td><td rowspan=1 colspan=1>0.0,0.0%</td><td rowspan=1 colspan=1>3.6, 1.4%</td></tr><tr><td rowspan=1 colspan=1>Serum High</td><td rowspan=1 colspan=1>522.4</td><td rowspan=1 colspan=1>5.8, 1.1.%</td><td rowspan=1 colspan=1>3.5, 0.7%</td><td rowspan=1 colspan=1>0.0, 0.0%</td><td rowspan=1 colspan=1>6.8, 1.3%</td></tr><tr><td rowspan=1 colspan=1>Plasma Low</td><td rowspan=1 colspan=1>130.2</td><td rowspan=1 colspan=1>2.4, 1.8%</td><td rowspan=1 colspan=1>0.5,0.4%</td><td rowspan=1 colspan=1>1.1,0.8%</td><td rowspan=1 colspan=1>2.7, 2.1%</td></tr><tr><td rowspan=1 colspan=1>Plasma Mid</td><td rowspan=1 colspan=1>338.0</td><td rowspan=1 colspan=1>4.1, 1.2%</td><td rowspan=1 colspan=1>0.0, 0.0%</td><td rowspan=1 colspan=1>0.0,0.0%</td><td rowspan=1 colspan=1>4.1, 1.2%</td></tr><tr><td rowspan=1 colspan=1>Plasma High</td><td rowspan=1 colspan=1>550.8</td><td rowspan=1 colspan=1>6.6, 1.2%</td><td rowspan=1 colspan=1>0.0,0.0%</td><td rowspan=1 colspan=1>4.4, 0.8%</td><td rowspan=1 colspan=1>7.9, 1.4%</td></tr></table>

<table><tr><td rowspan=2 colspan=1>AnalyteHDL-Cmg/dL</td><td rowspan=1 colspan=5>Precision (SD, %CV)</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Serum Low</td><td rowspan=1 colspan=1>47.6</td><td rowspan=1 colspan=1>1.8,3.8%</td><td rowspan=1 colspan=1>0.9, 1.9%</td><td rowspan=1 colspan=1>0.3, 0.7%</td><td rowspan=1 colspan=1>2.0, 4.3%</td></tr><tr><td rowspan=1 colspan=1>Serum Mid</td><td rowspan=1 colspan=1>76.4</td><td rowspan=1 colspan=1>1.9, 2.5%</td><td rowspan=1 colspan=1>0.0,0.0%</td><td rowspan=1 colspan=1>0.5, 0.7%</td><td rowspan=1 colspan=1>2.0, 2.6%</td></tr><tr><td rowspan=1 colspan=1>Serum High</td><td rowspan=1 colspan=1>105.7</td><td rowspan=1 colspan=1>1.8, 1.7%</td><td rowspan=1 colspan=1>0.0, 0.0%</td><td rowspan=1 colspan=1>1.5, 1.4%</td><td rowspan=1 colspan=1>2.4, 2.2%</td></tr><tr><td rowspan=1 colspan=1>Plasma Low</td><td rowspan=1 colspan=1>41.3</td><td rowspan=1 colspan=1>1.1, 2.6%</td><td rowspan=1 colspan=1>0.0,0.0%</td><td rowspan=1 colspan=1>0.7, 1.6%</td><td rowspan=1 colspan=1>1.3,3.1%</td></tr><tr><td rowspan=1 colspan=1>Plasma Mid</td><td rowspan=1 colspan=1>71.2</td><td rowspan=1 colspan=1>0.7, 1.0%</td><td rowspan=1 colspan=1>0.3,0.4%</td><td rowspan=1 colspan=1>1.0, 1.3%</td><td rowspan=1 colspan=1>1.2, 1.7%</td></tr><tr><td rowspan=1 colspan=1>Plasma High</td><td rowspan=1 colspan=1>102.9</td><td rowspan=1 colspan=1>2.2, 2.1%</td><td rowspan=1 colspan=1>1.5, 1.5%</td><td rowspan=1 colspan=1>0.0, 0.0%</td><td rowspan=1 colspan=1>2.7, 2.6%</td></tr></table>

<table><tr><td rowspan=2 colspan=1>AnalyteLDL-Cmg/dL</td><td rowspan=1 colspan=5>Precision (SD, %CV)</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Serum Low</td><td rowspan=1 colspan=1>92.4</td><td rowspan=1 colspan=1>2.1, 2.3%</td><td rowspan=1 colspan=1>0.7, 0.8%</td><td rowspan=1 colspan=1>1.0, 1.1%</td><td rowspan=1 colspan=1>2.4, 2.6%</td></tr><tr><td rowspan=1 colspan=1>Serum Mid</td><td rowspan=1 colspan=1>159.5</td><td rowspan=1 colspan=1>3.0, 1.9%</td><td rowspan=1 colspan=1>2.0, 1.2%</td><td rowspan=1 colspan=1>0.7, 0.4%</td><td rowspan=1 colspan=1>3.7, 2.3%</td></tr><tr><td rowspan=1 colspan=1>Serum High</td><td rowspan=1 colspan=1>345.6</td><td rowspan=1 colspan=1>5.9, 1.7%</td><td rowspan=1 colspan=1>3.9, 1.1%</td><td rowspan=1 colspan=1>0.0,0.0%</td><td rowspan=1 colspan=1>7.1,2.1%</td></tr><tr><td rowspan=1 colspan=1>Plasma Low</td><td rowspan=1 colspan=1>78.7</td><td rowspan=1 colspan=1>1.2,1.6%</td><td rowspan=1 colspan=1>0.6,0.8%</td><td rowspan=1 colspan=1>1.1, 1.4%</td><td rowspan=1 colspan=1>1.8,2.3%</td></tr><tr><td rowspan=1 colspan=1>Plasma Mid</td><td rowspan=1 colspan=1>214.8</td><td rowspan=1 colspan=1>5.5, 2.6%</td><td rowspan=1 colspan=1>0.7,0.3%</td><td rowspan=1 colspan=1>0.3,0.2%</td><td rowspan=1 colspan=1>5.6, 2.6%</td></tr><tr><td rowspan=1 colspan=1>Plasma High</td><td rowspan=1 colspan=1>364.8</td><td rowspan=1 colspan=1>5.9, 1.6%</td><td rowspan=1 colspan=1>2.5, 0.7%</td><td rowspan=1 colspan=1>7.2, 2.0%</td><td rowspan=1 colspan=1>9.6, 2.6%</td></tr></table>

<table><tr><td rowspan=2 colspan=1>AnalyteTriglyceridesmg/dL</td><td rowspan=1 colspan=5>Precision (SD, %CV)</td></tr><tr><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>Within-Run</td><td rowspan=1 colspan=1>BetweenRun</td><td rowspan=1 colspan=1>BetweenDay</td><td rowspan=1 colspan=1>Total</td></tr><tr><td rowspan=1 colspan=1>Serum Low</td><td rowspan=1 colspan=1>67.5</td><td rowspan=1 colspan=1>0.9, 1.4%</td><td rowspan=1 colspan=1>0.5,0.7%</td><td rowspan=1 colspan=1>0.9, 1.4%</td><td rowspan=1 colspan=1>1.4, 2.1%</td></tr><tr><td rowspan=1 colspan=1>Serum Mid</td><td rowspan=1 colspan=1>330.2</td><td rowspan=1 colspan=1>2.5,0.8%</td><td rowspan=1 colspan=1>1.6,0.5%</td><td rowspan=1 colspan=1>1.6,0.5%</td><td rowspan=1 colspan=1>3.4, 1.0%</td></tr><tr><td rowspan=1 colspan=1>Serum High</td><td rowspan=1 colspan=1>596.6</td><td rowspan=1 colspan=1>3.6,0.6%</td><td rowspan=1 colspan=1>0.0, 0.0%</td><td rowspan=1 colspan=1>2.3,0.4%</td><td rowspan=1 colspan=1>4.3,0.7%</td></tr><tr><td rowspan=1 colspan=1>Plasma Low</td><td rowspan=1 colspan=1>69.5</td><td rowspan=1 colspan=1>0.8, 1.2%</td><td rowspan=1 colspan=1>1.1,1.5%</td><td rowspan=1 colspan=1>1.8,2.5%</td><td rowspan=1 colspan=1>2.2, 3.2%</td></tr><tr><td rowspan=1 colspan=1>Plasma Mid</td><td rowspan=1 colspan=1>341.5</td><td rowspan=1 colspan=1>2.5,0.7%</td><td rowspan=1 colspan=1>2.4,0.7%</td><td rowspan=1 colspan=1>0.0,0.0%</td><td rowspan=1 colspan=1>3.5, 1.0%</td></tr><tr><td rowspan=1 colspan=1>Plasma High</td><td rowspan=1 colspan=1>601.0</td><td rowspan=1 colspan=1>6.0, 1.0%</td><td rowspan=1 colspan=1>7.3, 1.2%</td><td rowspan=1 colspan=1>9.6, 1.6%</td><td rowspan=1 colspan=1>13.5, 2.3%</td></tr></table>

<table><tr><td>Detection Limit: were analyzed using Deming regression.</td><td>Linearity/assay reportable range: Refer to previously cleared submission k113262 Traceability, Stability, Expected values (controls, calibrators, or methods): . Refer to previously cleared submission k1 13262 Expected values/Reference range: Refer to previously cleared submission k1 13262 Refer to previously cleared submission k113262 Analytical specificity: Refer to previously cleared submission k1 13262 Method Comparison/Bias Determination: Refer to previously cleared submission k1 13262 Matrix Comparison: Matrix comparison studies were carried out following guideline EP9-A2-IR. The studies consisted of running a series of paired serum (x) and lithium heparin plasma (y) specimens in singlicate with varying levels of analyte that cover the assay&#x27;s dynamic range on the ACE Axcel Clinical Chemistry System. Results</td></tr></table>

<table><tr><td rowspan="7"></td><td rowspan="7"></td><td>Reagent</td><td>Range</td><td>Results ACE Axcel Serum vs. Plasma Slope: 0.987</td></tr><tr><td>Cholesterol 54 pairs</td><td>24-574 mg/dL</td><td>Intercept: -1.9 Correlation: 0.9987 Std. Error Est: 4.7 Confidence Interval Slope: 0.974 to 1.001</td></tr><tr><td>HDL 53 pairs</td><td>6-112 mg/dL</td><td>Confidence Interval Intercept: -4.6 to 0.8 Slope: 1.011 Intercept: -1.1 Correlation: 0.9981</td></tr><tr><td rowspan="2"></td><td rowspan="2"></td><td>Std. Error Est: 1.5 Confidence Interval Slope: 0.993 to 1.028</td></tr><tr><td>Confidence Interval Intercept: -2.0 to -0.2</td></tr><tr><td rowspan="3">LDL 54 pairs</td><td rowspan="3">10-428 mg/dL</td><td>Slope: 1.006</td></tr><tr><td>Intercept: -1.6</td></tr><tr><td>Correlation: 0.9981 Std. Error Est: 4.7</td></tr><tr><td rowspan="3"></td><td rowspan="3">Triglycerides 55 pairs</td><td rowspan="3">34-994 mg/dL Confidence Interval Slope: 0.981 to 1.002</td><td>Confidence Interval Slope: 0.989 to 1.023 Confidence Interval Intercept: -3.7 to 0.5</td></tr><tr><td>Slope: 0.992</td></tr><tr><td>Intercept: -3.6 Correlation: 0.9993 Std. Error Est: 7.2</td></tr><tr><td>Conclusions:</td><td colspan="3">Based on the foregoing data, the device is safe and effective. These data also indicate substantial equivalence to the predicate device.</td></tr></table>

Alfa Wassermann Diagnostic Technologies, LLC c/o Hyman Katz, Ph. D.   
Vice President, Quality and Regulatory Affairs 4 Henderson Drive   
West Caldwell, NJ 07006

Re: k122757 Trade/Device Name: ACE Cholesterol Reagent, ACE HDL-C Reagent, ACE LDL-C Reagent, ACE Triglycerides Reagent Regulation Number: 21 CFR§ 862.1175 Regulation Name: Cholesterol (Total) Test System Regulatory Class: Class I, meets limitations per 21 CFR§ 862.9(c)(4) (9) Product Code: CHH, LBS, MRR, CDT Dated: September 6, 2012 Received: September 7, 2012

Dear Dr. Katz:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with allthe Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Devices and Radiological Health at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH'S Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-576-. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/Medical   
Devices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance...

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800 638-2041 or (301) 796-5680 or at its Internet address http://www.fda/gov/MedicalDevices/ResourcesforYou/Industry/default.htm

Sincerely yours,

![](images/f8e3e4942d8746ab230dcfc744b0028d4bd6bce0f5461370d92dd86218d412cc.jpg)

Courtney H. Lias, Ph.D   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostics and Radiological Health   
Center for Devices and Radiological Health

Enclosure

# Indications for Use

510(k) Number (if known): _k122757

Device Name: ACE Cholesterol Reagent

Indications for Use: The ACE Cholesterol Reagent is intended for the quantitative determination of cholesterol concentration using the ACE Axcel Clinical Chemistry System. Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.

Device Name: ACE HDL-C Reagent

Indications for Use: The ACE HDL-C Reagent is intended for the quantitative determination of high density lipoprotein cholesterol (HDL-C) concentration using the ACE Axcel Clinical Chemistry System. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.

# Indications for Use

510(k) Number (if known): _k122757

Device Name: ACE LDL-C Reagent

Indications for Use: The ACE LDL-C Reagent is intended for the quantitative determination of low density lipoprotein cholesterol (LDL-C) concentration using the ACE Axcel Clinical Chemistry System. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis, and various liver and renal diseases. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.

# Device Name: ACE Triglycerides Reagent

Indications for Use: The ACE Triglycerides Reagent is intended for the quantitative determination of triglyceride concentration using the ACE Axcel Clinical Chemistry System. Triglyceride measurements are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases involving lipid metabolism or various endocrine disorders. This test is intended for use in clinical laboratories or physician office laboratories. For in vitro diagnostic use only.

# Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

![](images/da250b81c83eabe606a453fd36f4da0c2269e8266df85a94afb5fa0a03e3e9c3.jpg)

Divisidh Sign(Øff   
Office of In Vitro Diagnostic Device   
Evaluation and Safety